New Milford, CT, United States of America

Gregory Paul Roth

USPTO Granted Patents = 6 


Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 117(Granted Patents)


Location History:

  • Woodstock, CT (US) (2006)
  • New Milford, CT (US) (1999 - 2009)

Company Filing History:


Years Active: 1999-2009

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Gregory Paul Roth: Innovator in Pharmaceutical Compounds

Introduction

Gregory Paul Roth is a notable inventor based in New Milford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address cytokine-mediated diseases and inflammatory conditions. With a total of 6 patents to his name, Roth's work is instrumental in advancing medical treatments.

Latest Patents

Roth's latest patents include innovative compounds such as benzofuran and benzothiophene derivatives. These compounds are designed to inhibit the production of cytokines involved in inflammatory processes, making them valuable for treating chronic inflammatory diseases. Additionally, he has developed substituted benzimidazole compounds that inhibit Itk kinase, which are useful for addressing immunological disorders and allergic conditions. Both patents also detail processes for preparing these compounds and pharmaceutical compositions that incorporate them.

Career Highlights

Gregory Paul Roth is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to contribute to pharmaceutical research and development. His expertise in creating compounds that target specific diseases showcases his commitment to improving healthcare outcomes.

Collaborations

Roth has collaborated with notable colleagues in his field, including Christopher Ronald Sarko and Charles Lawrence Cywin. These partnerships enhance the innovative potential of his work and contribute to the success of their projects.

Conclusion

Gregory Paul Roth's contributions to pharmaceutical innovations reflect his dedication to addressing critical health issues through scientific research. His patents and ongoing work at Boehringer Ingelheim Pharmaceuticals, Inc. position him as a key figure in the development of effective treatments for inflammatory and immunological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…